ABSTRACT Fifteen cases of open-heart surgery in patients with sickle-cell haemoglobinopathies are reported; 13 had sickle-cell trait, one had SC haemoglobinopathy, and one had ,8-thalassaemia sickle-cell disease. All patients except one were operated on with moderate hypothermia, aortic cross-clamping, topical hypothermia, and cold cardioplegia. A bloodless priming solution was used in nine patients and five did not receive any blood throughout their hospital stay. Arterial and venous blood gas analysis and a search for sickle cells and haemolysis were carried out during and after cardiopulmonary bypass. The data were compared with the findings in a group of 29 patients without haemoglobinopathy operated on without blood transfusion. Two patients died from low cardiac output, unrelated to the haemoglobinopathy. All other patients recovered uneventfully. Sickling occurred during and after bypass in only one case, and the percentage of sickle cells was considerably lower during and after surgery than before. Haemolysis occurred only once during cardiopulmonary bypass and twice after surgery (the two deaths from low cardiac output). There was no acidosis or hypoxia. There was no difference in the loss of haemoglobin between the 13 survivors and the control group. Our data suggest that adequate oxygenation and avoidance of acidosis and dehydration during surgery are important. On the other hand, we do not believe that preoperative transfusion or exchange transfusion, a blood prime, normothermia, and the avoidance of aortic cross-clamping or topical hypothermia are essential precautions. We believe that transfusion should be used during cardiopulmonary bypass only for severely anaemic patients. The technique used in our cases adds to the safety of the procedure and improves the protection of the myocardium.
The potential dangers to patients with sickle-cell haemoglobinopathies during operations requiring cardiopulmonary bypass have been emphasised by several authors.'-6 There have been only 11 reported cases; one of these patients died from sickle-cell thrombosis.7 Recommendations for precautions at cardiopulmonary bypass based on these patients include the use of exchange transfusions, preoperative transfusions, and blood in the priming solution and the avoidance of acidosis, hypoxia, hypothermia, aortic cross-clamping, and mechanical valvular prostheses. More recently, however, a case of successful cardiopulmonary bypass in a patient with sickle-cell trait was reported where aortic cross-clamping, cardioplegia, and topical hypothermia were used.8 We report our experience with 15 patients from the Ivory Coast with various sickling disorders who required open-heart surgery. We also show that several previously accepted precautions are not necessary. We have developed a technique for safer cardiopulmonary bypass with improved myocardial preservation that does not increase the risks inherent in these patients' condition.
Methods
The patients in this study were 15 black Africans aged 3-40 years (mean 18-6 years). Thirteen had sickle-cell trait and two a more complex sickling disorder-one SC haemoglobinopathy and one ,3-thalassaemia sickle-cell disease (table 1). All patients had their cardiac diagnosis confirmed by echocardiography, cardiac catheterisation, and left or right heart cineangiography. None had an obvi- ous history of sickle-cell crisis and only one patient CARDIOPULMONARY BYPASS (case 10) had splenomegaly. No patient had evi-A bubble oxygenator was used in all patients dence of preoperative haemolysis. Haemoglobin (Travenol 6 LF, Temptrol Q100, Q110, and BOS concentrations ranged from 7.4 to 24*9 g/dl (mean 10). Table 2 shows data concerning the conduct of 11-8 g/dl when two cyanotic patients with a high cardiopulmonary bypass and the procedures perhaemoglobin concentration are excluded). Only one formed. Ten patients had a bloodless priming solupatient (case 15) had a reticulocytosis-11%. Three tion and nine of these received no blood during patients had preoperative circulating sickle cells: surgery. Arterial and central venous blood gases patient 13 had 3% sickle cells in the venous blood were measured before cardiopulmonary bypass, and patient 15 had 27-50-the latter received one every 20 minutes during the operation, immediately unit of packed cells before operation. after the operation, and on return to the intensive Table 3 shows the results of investigations done The possible dangers of the sickle-cell haemoglobin states have led to many recommendations concerning the conduct of cardiopulmonary bypass in such patients.
(1) Optimal oxygenation must be maintained during and after surgery. Sickling may occur in the homozygous SS patient at oxygen tensions (Po2) below 5-3 kPa (40 mm Hg)5 to 6-0 kPa (45 mm Hg)." It can occur in the heterozygous state at a Po2 of 2-7 kPa (20 mm Hg)5 to 3-3 kPa (25 mm Hg)." It is therefore important to assure optimal oxygenation before, during, and after anaesthesia" and surgery and to avoid respiratory or metabolic acidosis. Although acidosis was thought to be the major triggering factor of sickling, this theory has would necessitate the use of blood in the priming solution.'-3 5 9 For some authors2 the latter would be sufficient to decrease the percentage of haemoglobin S.
(3) In the postoperative course, donor blood with haemoglobin S should be avoided. An electrophoresis of haemoglobin should therefore be performed on all donors.
(4) Systemic hypothermia increases blood viscosity and augments sickling and therefore on a theoretical basis has not been recommended.25 (5) Theoretically, aortic cross-clamping and the use of topical hypothermia was felt to cause in situ sickling. These techniques were therefore not recommended25 but more recently have been used successfully.8 12 (6) It has also been suggested that the use of prosthetic valves should be avoided because of potential mechanical trauma to erythrocytes.25 A Starr-Edwards-type prosthesis,' however, and a Bjork-Shiley prosthesis6 have been used without problems in two patients. Tricuspid insufficiency, which occurred after correction of one case of tetralogy of Fallot, led to mechanical trauma of red blood cells, haemolysis, and increased sickling after surgery.4
In the Ivory Coast haemoglobinopathies are frequent.'3 They affect 20% of the population, 11% having haemoglobin S (9.5% AS, 02% SS, 025% SC; and 1-07% S-Thal) and 7% having the C haemoglobinopathy. This poses a potential problem for open-heart surgery. The above recommendations for the conduct of cardiopulmonary bypass in these patients are quite contrary to our routine. We try to avoid the use of blood whenever possible, for reasons that include difficulties in procurement (particularly for the rare groups) and the transmission of parasitic disease, hepatitis, etc, which are common in Africa. We therefore use total haemodilution with reduced priming volume, moderate hypothermia (28°C), aortic cross-clamping, local cardiac hypothermia, and cold cardioplegia for myocardial protection. 
